Jorge A. Quiroz

Jorge brings twenty years of drug development experience from academia, and the pharmaceutical and biotechnology industries. He has been responsible for the scientific, clinical, and regulatory strategies across all phases of drug development, globally, including IND filings for rare disorders, and proof of concept and registrational studies for NDA and sNDA.

Prior to NMD Pharma, Jorge served as Chief Medical Officer of venture-backed and publicly-traded biotechnology companies focused on gene therapies for the treatment of neurodegenerative and neuromuscular disorders (Apic Bio and Solid Biosciences), as Head of Neurodevelopment and Psychiatry at Hoffmann-La Roche, and as Director of Translational Medicine at Johnson & Johnson. He has over 50 scientific publications in the fields of translational neuroscience and drug development.

Jorge is a medical graduate from the Pontifical Catholic University of Chile and completed a fellowship at the Laboratory of Molecular Pathophysiology at the National Institute of Mental Health in Bethesda, MD, USA. He also holds a Master of Business Administration dual degree from Columbia University & London Business School.